Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Procter & Gamble Co. (NYSE:PG) reported Thursday that shareholders approved a new stock and incentive compensation plan and reelected all director nominees during the company’s annual meeting held Tuesday.
According to a statement based on a Securities and Exchange Commission filing, shareholders approved The Procter & Gamble 2025 Stock and Incentive Compensation Plan, which authorizes the issuance of up to 175 million shares of common stock for awards. The plan allows for various forms of equity compensation, including common stock, restricted stock units, performance stock units, stock options, and stock appreciation rights. Any shares remaining from the company’s 2019 stock plan may also be awarded under the new plan.
All director nominees were elected to one-year terms. Voting results showed each candidate received at least 1.6 billion votes in favor. Directors elected include B. Marc Allen, Craig Arnold, Brett Biggs, Sheila Bonini, Amy L. Chang, Shailesh Jejurikar, Joseph Jimenez, Christopher Kempczinski, Debra L. Lee, Christine M. McCarthy, Ashley McEvoy, Jon R. Moeller, Robert J. Portman, and Rajesh Subramaniam.
Shareholders also ratified the appointment of the company’s independent registered public accounting firm, with more than 1.89 billion votes in favor.
An advisory vote to approve executive compensation, known as the “Say on Pay” vote, was approved by shareholders, with approximately 1.53 billion votes in favor and about 129 million against.
A shareholder proposal requesting additional reporting on plastic packaging was not approved. The proposal received around 230 million votes in favor and 1.42 billion votes against.
The information in this article is based on a statement from Procter & Gamble’s recent SEC filing.
In other recent news, Procter & Gamble reported its fiscal fourth-quarter 2025 earnings, exceeding analysts’ expectations with an earnings per share of $1.48, compared to the forecasted $1.42. The company’s revenue also surpassed projections, reaching $20.89 billion against the anticipated $20.81 billion. Procter & Gamble’s Board of Directors declared a quarterly dividend of $1.0568 per share, payable on or after November 17, 2025, to shareholders of record as of October 24, 2025. In leadership news, Alexandra Keith, CEO of the Beauty division, announced her retirement effective February 20, 2026. TD Cowen lowered its price target for Procter & Gamble to $168.00 from $175.00, citing challenges in fiscal year 2026, including category slowdowns in developed markets. Despite this, UBS reiterated its Buy rating on the stock, maintaining a price target of $180.00, noting progress in the company’s fourth-quarter performance. These developments reflect Procter & Gamble’s ongoing adjustments in strategy and leadership amidst varying market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.